Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

Leukaemias and other cancers possess a rare population of cells capable of the limitless self-renewal necessary for cancer initiation and maintenance. Eradication of these cancer stem cells is probably a critical part of any successful anti-cancer therapy, and may explain why conventional cancer therapies are often effective in reducing tumour burden, but are only rarely curative.

, , , , , , , , , , &

To read this article in full you may need to log in, make a payment or gain access through a site license (see right).